Aflibercept and Bevacizumab for Diabetic Maculopathies

Clinical trial NCT06850571 · RECRUITING

Trial details

NCT number: NCT06850571
Sponsor: Al-Mustansiriyah University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Maculopathy

Start date: 2025-02-20
Primary completion: 2025-12-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.